Takeshi Kuwata Selected Research

Takeshi Kuwata Research Topics

Disease

68	Neoplasms (Cancer) 09/2022 - 01/2003
32	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2012
14	Adenocarcinoma 11/2021 - 04/2012
10	Endometrial Neoplasms (Endometrial Cancer) 11/2013 - 01/2003
7	Carcinoma (Carcinomatosis) 10/2016 - 05/2004
6	Adenocarcinoma of Lung 12/2018 - 01/2016
5	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2010
5	Hypoxia (Hypoxemia) 01/2022 - 11/2013
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 10/2015
4	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 12/2013
3	Disease Progression 01/2021 - 01/2020
3	Residual Neoplasm 01/2021 - 07/2015
2	Necrosis 04/2021 - 01/2019
2	Microsatellite Instability 03/2021 - 01/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2019 - 01/2017
2	Leukemia 01/2019 - 05/2004
2	Lung Neoplasms (Lung Cancer) 05/2018 - 08/2010
2	Carcinogenesis 06/2014 - 08/2012
2	Carcinosarcoma 09/2013 - 06/2009
1	Adenoma (Adenomas) 11/2021
1	Lymphoma (Lymphomas) 10/2021
1	Epstein-Barr Virus Infections 01/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2020
1	Proteinuria 01/2020
1	Exanthema (Rash) 01/2020
1	Cachexia 03/2019

Drug/Important Bio-Agent (IBA)

9	Immune Checkpoint InhibitorsIBA 09/2022 - 01/2020
9	Biomarkers (Surrogate Marker)IBA 03/2021 - 12/2013
8	Biological ProductsIBA 09/2020 - 08/2010
7	human ERBB2 proteinIBA 01/2021 - 01/2014
7	Trastuzumab (Herceptin)FDA Link 01/2021 - 05/2011
6	Proteins (Proteins, Gene)FDA Link 11/2021 - 05/2012
6	Cadherins (E-Cadherin)IBA 01/2021 - 06/2009
6	beta CateninIBA 06/2009 - 01/2003
5	NivolumabIBA 01/2022 - 01/2019
5	CytokinesIBA 01/2021 - 10/2010
5	ErbB Receptors (EGF Receptor)IBA 11/2020 - 01/2015
5	ezrinIBA 01/2018 - 01/2016
4	pembrolizumabIBA 01/2022 - 01/2019
4	CateninsIBA 01/2022 - 12/2010
4	LigandsIBA 01/2021 - 05/2011
4	Carbonic Anhydrase IXIBA 01/2021 - 01/2018
4	ParaffinIBA 12/2020 - 11/2012
4	KalininIBA 07/2019 - 01/2016
3	AntibodiesIBA 01/2022 - 05/2017
3	Phosphotransferases (Kinase)IBA 10/2021 - 01/2019
3	Pharmaceutical PreparationsIBA 06/2021 - 05/2011
3	Formaldehyde (Formol)FDA Link 12/2020 - 01/2015
3	Small Interfering RNA (siRNA)IBA 03/2019 - 11/2012
3	Tumor Suppressor Protein p14ARF (p14ARF)IBA 08/2012 - 11/2006
2	lenvatinibIBA 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2015
2	regorafenibIBA 01/2022 - 01/2020
2	VimentinIBA 01/2021 - 09/2013
2	B7-H1 AntigenIBA 01/2021 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 06/2018
2	tyrosine receptor (receptor, tyrosine)IBA 01/2020 - 01/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 04/2015
2	Monoclonal AntibodiesIBA 01/2019 - 01/2018
2	Epidermal Growth Factor (EGF)IBA 01/2018 - 05/2014
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 11/2017 - 03/2017
2	Becaplermin (PDGF-BB)FDA Link 01/2017 - 08/2010
2	CollagenIBA 01/2017 - 08/2015
2	Growth Factor ReceptorsIBA 01/2017 - 10/2016
2	Transcription Factors (Transcription Factor)IBA 08/2012 - 05/2004
2	Cyclin-Dependent Kinase Inhibitor p16IBA 09/2007 - 11/2006
2	Cyclin D1IBA 11/2006 - 05/2004
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Prostaglandins AIBA 11/2021
1	DesminIBA 10/2021
1	Calmodulin-Binding Proteins (Caldesmon)IBA 10/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2021
1	Indicators and Reagents (Reagents)IBA 04/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	trastuzumab deruxtecanIBA 01/2021
1	Lapatinib (GW572016)FDA Link 01/2021
1	Ado-Trastuzumab EmtansineIBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	napabucasinIBA 11/2020
1	Programmed Cell Death 1 ReceptorIBA 11/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 01/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 03/2019
1	amsonic acid (DAS)IBA 01/2019
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019

Therapy/Procedure

17	Therapeutics 01/2022 - 01/2003
13	Drug Therapy (Chemotherapy) 09/2022 - 09/2012
3	Immunotherapy 01/2022 - 01/2019
3	Neoadjuvant Therapy 01/2021 - 09/2012
2	Gastrectomy 01/2019 - 04/2012
1	Genomic Medicine 11/2021
1	Chemoradiotherapy 08/2021
1	Nephrectomy 04/2021
1	Metastasectomy 05/2019